Trials / Conditions / Obstructive Hypertrophic Cardiomyopathy (oHCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

10 registered clinical trials studyying Obstructive Hypertrophic Cardiomyopathy (oHCM) — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Var NCT07439952	Assistance Publique - Hôpitaux de Paris	—
Recruiting	Ademetionine in Obstructive Hypertrophic Cardiomyopathy NCT07367724	China National Center for Cardiovascular Diseases	Phase 2
Recruiting	Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan NCT07383025	Bristol-Myers Squibb	—
Completed	Real-World Effectiveness of Mavacamten in Canada NCT06338202	Bristol-Myers Squibb	—
Completed	Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy NCT07529938	Chinese Academy of Medical Sciences, Fuwai Hospital	—
Active Not Recruiting	A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US NCT07107373	Bristol-Myers Squibb	—
Completed	Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With NCT05767346	Cytokinetics	Phase 3
Completed	Mavacamten in Obstructive Hypertrophic Cardiomyopathy NCT07168655	Bristol-Myers Squibb	—
Completed	Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic NCT05186818	Cytokinetics	Phase 3
Completed	Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopath NCT06609382	Changrong Nie	—